TARSONSMedical Equipment & Supplies
Tarsons Products Ltd — Cash Flow Statement
₹166.46
-4.31%
Tarsons Products Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Financing Cash Flow | 38.95 Cr | 135.63 Cr | 84.56 Cr | 129.57 Cr | — |
| Net Other Financing Charges | -10.63 Cr | — | — | — | — |
| Interest Paid Cff | -18.86 Cr | -9.56 Cr | -4.53 Cr | -4.26 Cr | — |
| Net Issuance Payments Of Debt | 71.74 Cr | 145.96 Cr | 89.09 Cr | -11.83 Cr | — |
| Net Short Term Debt Issuance | -33.00 Cr | 102.18 Cr | -1.00 Cr | -22.15 Cr | — |
| Short Term Debt Payments | -1.44K Cr | -41.02 Cr | -9.90 Cr | -258.15 Cr | — |
| Short Term Debt Issuance | 1.40K Cr | 143.20 Cr | 8.90 Cr | 236.00 Cr | — |
| Net Long Term Debt Issuance | 104.73 Cr | 43.78 Cr | 90.09 Cr | 10.32 Cr | — |
| Long Term Debt Payments | -58.70 Cr | -41.74 Cr | -15.07 Cr | -33.00 Cr | — |
| Long Term Debt Issuance | 163.43 Cr | 85.53 Cr | 105.17 Cr | 43.32 Cr | — |
| Investing Cash Flow | -145.49 Cr | -284.96 Cr | -178.55 Cr | -137.94 Cr | — |
| Interest Received Cfi | 1.25 Cr | 1.65 Cr | 3.37 Cr | 0.85 Cr | — |
| Net Investment Purchase And Sale | 4.07 Cr | -4.47 Cr | 6.99 Cr | -6.93 Cr | — |
| Sale Of Investment | 87.56 Cr | 0.42 Cr | 6.99 Cr | 173.94 Cr | — |
| Purchase Of Investment | -83.50 Cr | -4.90 Cr | 0.00 | -180.87 Cr | — |
| Net Business Purchase And Sale | 0.00 | -65.14 Cr | — | — | — |
| Purchase Of Business | 0.00 | -65.14 Cr | — | — | — |
| Net PPE Purchase And Sale | -150.80 Cr | -184.00 Cr | -188.91 Cr | -131.87 Cr | — |
| Sale Of PPE | 0.91 Cr | 0.33 Cr | 1.06 Cr | 0.10 Cr | — |
| Purchase Of PPE | -151.71 Cr | -184.33 Cr | -189.97 Cr | -131.97 Cr | — |
| Operating Cash Flow | 114.24 Cr | 102.70 Cr | 75.60 Cr | 83.47 Cr | — |
| Taxes Refund Paid | -15.84 Cr | -18.40 Cr | -24.30 Cr | -33.38 Cr | — |
| Change In Working Capital | -0.96 Cr | 8.58 Cr | -36.32 Cr | -41.81 Cr | — |
| Change In Other Current Liabilities | -0.46 Cr | 2.66 Cr | -1.42 Cr | 3.77 Cr | — |
| Change In Other Current Assets | -4.25 Cr | 6.58 Cr | 1.12 Cr | 1.74 Cr | — |
| Change In Payable | -0.08 Cr | -0.61 Cr | -3.11 Cr | 5.97 Cr | — |
| Change In Inventory | 2.78 Cr | 7.51 Cr | -32.00 Cr | -35.70 Cr | — |
| Change In Receivables | -1.48 Cr | -7.41 Cr | 0.23 Cr | -17.82 Cr | — |
| Other Non Cash Items | 15.80 Cr | 6.59 Cr | 0.30 Cr | 2.11 Cr | — |
| Provisionand Write Offof Assets | 10.22 Cr | 4.15 Cr | -0.44 Cr | 0.28 Cr | — |
| Depreciation And Amortization | 62.50 Cr | 40.40 Cr | 28.51 Cr | 21.96 Cr | — |
| Depreciation | 62.50 Cr | 40.40 Cr | 28.36 Cr | 21.82 Cr | — |
| Net Foreign Currency Exchange Gain Loss | -1.91 Cr | 0.55 Cr | -0.60 Cr | -0.65 Cr | — |
| Gain Loss On Sale Of PPE | -0.37 Cr | 0.07 Cr | -0.27 Cr | -0.04 Cr | — |
| Net Income From Continuing Operations | 44.80 Cr | 60.77 Cr | 108.72 Cr | 134.99 Cr | — |
| Free Cash Flow | -37.47 Cr | -81.63 Cr | -114.37 Cr | -48.50 Cr | — |
| Repayment Of Debt | -1.49K Cr | -82.76 Cr | -24.98 Cr | -291.15 Cr | — |
| Issuance Of Debt | 1.57K Cr | 228.72 Cr | 114.07 Cr | 279.32 Cr | — |
| Capital Expenditure | -151.71 Cr | -184.33 Cr | -189.97 Cr | -131.97 Cr | — |
| End Cash Position | 25.13 Cr | 17.11 Cr | 59.06 Cr | 77.44 Cr | — |
| Beginning Cash Position | 17.11 Cr | 63.79 Cr | 77.44 Cr | 2.33 Cr | — |
| Effect Of Exchange Rate Changes | 0.32 Cr | -0.05 Cr | 40000.00 | 0.01 Cr | — |
| Changes In Cash | 7.70 Cr | -46.63 Cr | -18.39 Cr | 75.10 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | 30000.00 | — | 0.03 Cr | 70000.00 |
| Net Other Investing Changes | — | -10000.00 | — | — | — |
| Amortization Cash Flow | — | 1.38 Cr | 0.15 Cr | 0.14 Cr | 0.00 |
| Issuance Of Capital Stock | — | — | 0.00 | 149.70 Cr | 0.00 |
| Net Common Stock Issuance | — | — | 0.00 | 149.70 Cr | -22.00 Cr |
| Common Stock Issuance | — | — | 0.00 | 149.70 Cr | 0.00 |
| Repurchase Of Capital Stock | — | — | — | 0.00 | -22.00 Cr |
| Common Stock Payments | — | — | — | 0.00 | -22.00 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Tarsons Products Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.